Research Challenge: Health

Understand the biological and psychosocial characteristics of cancer

ADCs and Immune Modulation - Understanding and Managing Immune-Related Side Effects of Anti-Cancer Treatments

The role of non-coding mutations as predictors of treatment response in breast cancer

Representing the cancer ecosystem; developing experimental systems from complex cell culture to animal models

OvaLoad: Enhanced targeted DNA damage in ovarian cancer

Developing new targeted treatment strategies for triple negative breast cancer

Investigating new therapeutic modalities for a rare childhood cancer

Immune responses to intratumoural bacteria in cancer

Discover new therapeutic interventions using chemistry, drug screening, and novel delivery technologies

Rational therapeutic combinations with DXd-based ADCs

Investigating the combination of tyrosine kinase inhibitors and antibody-drug conjugates in HER2+ cancers

Decoding the TP53 enigma: Investigating the impact of TP53 mutations on non-transcriptional regulation of calcium-mediated apoptotic sensitivity in Triple Negative Breast Cancer

Bridging laboratory findings to clinical applications through biomarker discovery and collaborative trials

Breast cancer biomarkers and novel treatment strategies

Characterising the immune response to antibody-based therapies in cancer